IF YOU PURCHASED PACB COMMON STOCK ON OR ABOUT OCTOBER 27, 2010 THROUGH AND INCLUDING SEPTEMBER 20, 2011, INCLUDING IF YOU PURCHASED THE COMPANY'S STOCK PURSUANT AND/OR TRACEABLE TO THE COMPANY'S REGISTRATION STATEMENT AND PROSPECTUS FILED WITH THE SEC IN CONNECTION WITH THE COMPANY'S OCTOBER 27, 2010 IPO, YOUR RIGHTS MAY BE AFFECTED BY THE SETTLEMENT OF THIS ACTION.
To share in the distribution of the Settlement Fund, you must establish your rights by filing a Proof of Claim on or before October 16, 2013. Your failure to submit your Proof of Claim by October 16, 2013 will subject your claim to rejection and preclude your receiving any of the recovery in connection with the Settlement of this Action. If you are a member of the Class and do not request exclusion therefrom, you will be bound by the Settlement and any judgment and Release entered in the Action, including, but not limited to, the Final Order, whether or not you submit a Proof of Claim.
If you have not received a copy of the Notice, which more completely describes the Settlement and your rights thereunder (including your right to object to the Settlement), and a Proof of Claim form, you may obtain these documents, as well as a copy of the Stipulation (which among other things contains definitions for the defined terms used in this Summary Notice) and other settlement documents, online at www.PacificBiosciencesSecuritiesLitigation.com, or by writing to:
Pacific Biosciences Securities Litigation Settlement
P.O. Box 35072
Seattle, WA 98124-3508
Phone: (866) 297-1225
Inquiries should NOT be directed to Defendants, the Court, or the Clerk of the Court.
Inquiries, other than requests for the Notice
|SOURCE Robbins Geller Rudman & Dowd LLP; Scott+Scott, Attorneys at Law, LLP|
Copyright©2012 PR Newswire.
All rights reserved